Psoriatic arthritis
- Psoriasis affects 1% of the population
- 5% of patients with psoriasis will develop psoriatic arthropathy
- 15-20% of adults will develop joint disease before skin lesions appear
- people with severe arthritis can have little or no skin disease, and vice versa
- flare-ups of symptoms do not necessarily coincide
- The condition has a genetic component:
- HLA-DR4 is a risk factor for psoriatic and rheumatoid arthritis
- patients with psoriatic spondylitis share HLA-B27 with other spondylitic patients
Clinical features
- Skin
- Most commonly, psoriasis, a skin disease, appears first, followed by psoriatic arthritis. However, in a minority of cases, joint problems can start before any skin manifestations appear.
- The severity of the skin disease does not predict the severity of the joint disease.
- Plaque psoriasis (Well-demarcated erythematous plaques with silvery scale) is the most common form of skin psoriasis seen with psoriatic arthritis. Joint symptoms may be exacerbated by a flare in skin psoriasis but quite commonly the skin symptoms behave independently of joint symptoms.
- Most people with psoriatic arthritis have mild psoriasis.
- Joints :
- 5 Subtypes:
- Oligoarticular arthritis: Asymmetric, <5 joints involved -Most common – 60% of cases
- Polyarticular arthritis: Symmetric, resembles rheumatoid arthritis, negative for rheumatoid factor.
- Distal arthritis: Prominent DIP joint involvement.
- Arthritis mutilans: Severe, destructive joint disease causing deformities.
- Spondyloarthritis: Involves sacroiliitis and spondylitis, with or without peripheral joint disease.
- 5 Subtypes:
- Dactylitis – are characteristic of psoriatic arthritis in the hands enthesitis
- differentials below
- Nail disease – severity of nail disease correlates with the severity of both skin and joint diseas
- transverse or longitudinal ridging
- discolouration
- subungual hyperkeratosis
- onycholysis
- pitting
- splinter hemorrhages
- Eyes
- Conjunctivitis, iritis
- Heart and lung (late findings)
- Aortic insufficiency
- Apical lung fibrosis
- Peripheral NS
- Cauda equina claudication
Investigations
- are no diagnostic blood tests for psoriatic arthritis but tests may be done to help confirm the diagnosis and rule out other causes
- WBC – usually raised
- ESR and CRP – usually raised
- Hypergammaglobulinaemia
- Rheumatoid factor – usually negative but may be positive in up to 10% of patients with psoriatic arthritis
- Anti-CCP – usually negative but may be positive in up to 7% of patients with psoriatic arthritis.
- HLA-B27 testing
- Imaging : Xray
- Erosive changes of the DIP seen in radiography may be used as both a sensitive and specific diagnostic feature of psoriatic arthritis
- joint erosions and joint space narrowing
- bony proliferation including periarticular and shaft periostitis,
- osteolysis including “pencil in cup’ deformity,
- acro-osteolysis
- ankylosis
- spur formation
- spondylitis
- Other conditions with similar clinical and X-ray findings to psoriatic arthritis include:
- Rheumatoid arthritis (RA)
- Gout
- Osteoarthritis (OA)
- Reactive arthritis(ReA)
- Ankylosing spondylitis (AS)
- but Psoriatic arthritis shares features with RA, ReA, AS but has distinct characteristics like DIP joint involvement and asymmetric sacroiliitis.
Treatment Approaches
- mild cases
- NSAIDs
- moderate cases
- csDMARDs (like Methotrexate, Sulfasalazine),
- severe cases
- bDMARDs (TNF inhibitors, IL-17 inhibitors)
- tsDMARDs (JAK inhibitors, PDE-4 inhibitors).
Disease Monitoring:
- Regular assessment of disease activity
- using tender and swollen joint counts
- BASDAI
- Health-related QoL measures, and other composite indices.
Non-Pharmacological Treatment
- Education: regarding the disease and about joint protection
- Physical Therapy: Tailored exercises to improve joint function and reduce pain.
- Occupational Therapy: Strategies for daily activities to minimize joint stress.
- Weight Management: Maintaining a healthy weight to reduce stress on joints.
- Exercise: Regular, moderate exercise to maintain joint flexibility and muscle strength.
- Dietary Adjustments: Anti-inflammatory diet may help reduce symptoms.
- Stress Management: Techniques like meditation or yoga to manage stress which can exacerbate PsA symptoms.
- Heat and Cold Therapy: To relieve pain and reduce inflammation.
- Assistive Devices: Tools to help with mobility and daily tasks.
- Education and Support: Understanding the condition and finding support groups.
prognosis
- Psoriatic arthritis can be an aggressive disease impacting quality of life.
- Most people with psoriatic arthritis will have ongoing problems with arthritis throughout the rest of their life.
- Remissions are uncommon; occurring in less than 20% of patients with less than 10% of patients having a complete remission off all medication with no signs of joint damage on X-rays.
- People with severe psoriatic arthritis have been reported to have a shorter lifespan than average.
Features associated with a relatively good prognosis are:
- Male sex
- Fewer joints involved
- Good functional status at presentation
- Previous remission in symptoms.
Features associated with a poor prognosis include:
- ESR > 15 mm/hr or raised CRP at presentation
- Failure of previous medication trials
- Absence of nail changes
- Joint damage (clinically or radiographically)
- HLA-B27-, -B39-, or -DQw3-positive status.
Dactylitis – differentials
- Infection-Related Dactylitis:
- Blistering distal dactylitis: Common in children, caused by streptococcus or staphylococcus.
- Tuberculous dactylitis: Rare, a form of osteomyelitis in hands and feet, linked to tuberculosis.
- Syphilitic dactylitis: Associated with congenital syphilis, bilateral and symmetrical involvement.
- Spondyloarthritis:
- Common in psoriatic arthritis, reactive arthritis, ankylosing spondylitis.
- Indicates disease severity in psoriatic arthritis, often affecting feet.
- Other Conditions:
- Gout: Up to 5% incidence, related to urate crystal deposition.
- Sarcoidosis: Rare, associated with lupus pernio, causes bilateral finger swellings.
- Sickle-cell dactylitis: Common in sickle-cell anemia, especially in early childhood, often the first sign of the disorder.